SEARCH

SEARCH BY CITATION

References

  • Bailey, E.M., Krakovsky, D.J. & Rybak, M.J. (1990) The triazole antifungal agents: a review of itraconazole and fluconazole. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 10, 146153.
  • Blanshard, W. (1994) Medicine and husbandry of koalas. Proceedings of Wildlife: The T G Hungerford Refresher Course for Veterinarians. Post Graduate Committee in Veterinary Science, the University of Sydney, pp. 547626, South Sydney, NSW.
  • Blanshard, W. & Bodley, K. (2008). Koalas. In Medicine of Australian Mammals. Eds Vogelnest, L. & Woods, R., pp. 227327. CSIRO Publishing, Collingwood, Vic.
  • Brammer, K.W., Farrow, P.R. & Faulkner, J.K. (1990) Pharmacokinetics and tissue penetration of fluconazole in humans. Reviews of Infectious Diseases, 12, S318S326.
  • Burgess, J.L. & Birchall, R. (1972) Nephrotoxicity of amphotericin B, with emphasis on changes in tubular function. The American Journal of Medicine, 53, 7784.
  • Burgess, D.S. & Hastings, R.W. (2000) A comparison of dynamic characteristics of fluconazole, itraconazole, and amphotericin B against Cryptococcus neoformans using time-kill methodology. Diagnostic Microbiology and Infectious Disease, 38, 8793.
  • Canfield, P.M., O'Neill, M.E. & Smith, E.F. (1989) Haematological and biochemical reference values for the koala (Phascolarctos cinereus). Australian Veterinary Journal, 66, 324326.
  • Connolly, J.H., Krockenberger, M.B., Malik, R., Canfield, P.J., Wigney, D.I. & Muir, D.B. (1999) Asymptomatic carriage of Cryptococcus neoformans in the nasal cavity of the koala (Phascolarctos cinereus). Medical Mycology, 37, 331338.
  • Cork, S.J. & Foley, W.J. (1997) Digestive and metabolic adaptations of arboreal marsupials for dealing with plant antinutrients and toxins. In Marsupial Biology: Recent Research, New Perspectives. Eds Saunders, N.R. & Hinds, L.A., pp. 204226. University of New South Wales Press Ltd, Sydney, Australia.
  • Craig, A.J., Ramzan, I. & Malik, R. (1994) Pharmacokinetics of fluconazole in cats after intravenous and oral administration. Research in Veterinary Science, 57, 372376.
  • Davis, J.L., Papich, M.G. & C., H.M. (2009) Antifungal and antiviral drugs. In Veterinary Pharmacology and Therapeutics. 9th edn. Eds Riviere, J.E. & Papich, M., pp. 10131049. Wiley-Blackwell, Ames, Iowa.
  • Degabriele, R. & Dawson, T.J. (1979) Metabolism and heat balance in an arboreal marsupial, the koala (Phascolarctos cinereus). Journal of Comparative Physiology B: Biochemical, Systemic, and Environmental Physiology, 134, 293301.
  • Dow, N. (2006) Determination of compound binding to plasma proteins. Current Protocols in Pharmacology, 34, 7.5.17.5.15.
  • van Duijkeren, E., Kessels, B.G.F., Sloet van Oldruiten-Borgh-Oosterbaan, M.M., Breukink, H.J., Vulto, A.G. & van Miert, A.S.J.P.A.M. (1996) In vitro and in vivo binding of trimethoprim and sulphachlorpyridazine to equine food and digesta and their stability in caecal contents. Journal of Veterinary Pharmacology and Therapeutics, 19, 281287.
  • Ellis, W.A.H. & Carrick, F.N. (1992) Total body water and the estimation of fat in the koala (Phascolarctos cinereus). Australian Veterinary Journal, 69, 229231.
  • Ellis, D.H. & Pfeiffer, T.J. (1990) Natural habitat of Cryptococcus neoformans var. gattii. Journal of Clinical Microbiology, 28, 16421644.
  • Espinel-Ingroff, A., Aller, A.I., Canton, E., Castañón-Olivares, L.R., Chowdhary, A., Cordoba, S., Cuenca-Estrella, M., Fothergill, A., Fuller, J., Govender, N., Hagen, F., Illnait-Zaragozi, M.T., Johnson, E., Kidd, S., Lass-Flörl, C., Lockhart, S.R., Martins, M.A., Meis, J.F., Melhem, M.S.C., Ostrosky-Zeichner, L., Pelaez, T., Pfaller, M.A., Schell, W.A., St-Germain, G., Trilles, L. & Turnidge, J. (2012) Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole. Antimicrobial Agents and Chemotherapy, 56, 58985906.
  • Foulds, G., Brennan, D.R., Wajszczuk, C., Catanzaro, A., Garg, D., Knopf, W., Rinaldi, M. & Weidler, D.J. (1988) Fluconazole penetration into cerebrospinal fluid in humans. The Journal of Clinical Pharmacology, 28, 363366.
  • George, C.F. (1981) Drug metabolism by the gastrointestinal mucosa. Clinical Pharmacokinetics, 6, 259274.
  • Gomez-Lopez, A., Zaragoza, O., Dos Anjos Martins, M., Melhem, M.C., Rodriguez-Tudela, J.L. & Cuenca-Estrella, M. (2008) In vitro susceptibility of Cryptococcus gattii clinical isolates. Clinical Microbiology and Infection, 14, 727730.
  • Griffith, J.E., Higgins, D.P., Li, K.M., Krockenberger, M.B. & Govendir, M. (2010) Absorption of enrofloxacin and marbofloxacin after oral and subcutaneous administration in diseased koalas (Phascolarctos cinereus). Journal of Veterinary Pharmacology and Therapeutics, 33, 595604.
  • Humphrey, M.J., Jevons, S. & Tarbit, M.H. (1985) Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans. Antimicrobial Agents and Chemotherapy, 28, 648653.
  • Hunter, R.P. & Isaza, R. (2008) Concepts and issues with interspecies scaling in zoological pharmacology. Journal of Zoo and Wildlife Medicine, 39, 517526.
  • Ilett, K.F., Tee, L.B.G., Reeves, P.T. & Minchin, R.F. (1990) Mebolism of drugs and other xenobiotics in the gut lumen and wall. Pharmacology & Therapeutics, 46, 6793.
  • International Conference on Harmonisation. (2005) ICH Harmonised Tripartite guideline: Validation of Analytical Procedures: Text and Methodology Q2 (R1). International Conference on Harmonisation, Geneva, Switzerland.
  • Jezequel, S.G. (1994) Fluconazole: interspecies scaling and allometric relationships of pharmacokinetic properties. Journal of Pharmacy and Pharmacology, 46, 196199.
  • Kimble, B., Black, L.A., Li, K.M., Valtchev, P., Gilchrist, S., Gillett, A., Higgins, D.P., Krockenberger, M.B. & Govendir, M. (2013) Pharmacokinetics of meloxicam in koalas (Phascolarctos cinereus) after intravenous, subcutaneous and oral administration. Journal of Veterinary Pharmacology and Therapeutics. DOI: 10.1111/jvp.12038.
  • Klepser, M.E., Wolfe, E.J. & Pfaller, M.A. (1998) Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B against Cryptococcus neoformans. Journal of Antimicrobial Chemotherapy, 41, 397401.
  • Krockenberger, M.B., Canfield, P.J. & Malik, R. (2002) Cryptococcus neoformans in the koala (Phascolarctos cinereus): colonization by C. n. var. gattii and investigation of environmental sources. Medical Mycology, 40, 263272.
  • Krockenberger, M.B., Canfield, P.J. & Malik, R. (2003) Cryptococcus neoformans var. gattii in the koala (Phascolarctos cinereus): a review of 43 cases of cryptococcosis. Medical Mycology, 41, 225234.
  • Krockenberger, M., Stalder, K., Malik, R. & Canfield, P. (2005) Cryptococcosis in Australian wildlife. Microbiology Australia, 26, 6971.
  • Latimer, F.G., Colitz, C.M.H., Campbell, N.B. & Papich, M.G. (2001) Pharmacokinetics of fluconazole following intravenous and oral administration and body fluid concentrations of fluconazole following repeated oral dosing in horses. American Journal of Veterinary Research, 62, 16061611.
  • Lees, P., Taylor, J.B., Higgins, A.J. & Sedgwick, A.D. (1988) In vitro and in vivo binding of phenylbutazone and related drugs to equine feeds and digesta. Research in Veterinary Science, 44, 5056.
  • Liapis, P., Pass, G.J., McKinnon, R.A. & Stupans, I. (2000) Characterisation of tolbutamide hydroxylase activity in the common brushtail possum, (Trichosurus vulpecula) and koala (Phascolarctos cinereus): inhibition by the Eucalyptus terpene 1,8-cineole. Comparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology, 127, 351357.
  • Louie, A., Drusano, G.L., Banerjee, P., Liu, Q.-F., Liu, W., Kaw, P., Shayegani, M., Taber, H. & Miller, M.H. (1998a) Pharmacodynamics of fluconazole in a murine model of systemic candidiasis. Antimicrobial Agents and Chemotherapy, 42, 11051109.
  • Louie, A., Liu, Q.-F., Drusano, G.L., Liu, W., Mayers, M., Anaissie, E. & Miller, M.H. (1998b) Pharmacokinetic studies of fluconazole in rabbits characterizing doses which achieve peak levels in serum and area under the concentration-time curve values which mimic those of high-dose fluconazole in humans. Antimicrobial Agents and Chemotherapy, 42, 15121514.
  • Mahmood, I. & Balian, J.D. (1996) Interspecies scaling: a comparative study for the prediction of clearance and volume using two or more than two species. Life Sciences, 59, 579585.
  • Martin, R.W. (1981) Age-specific fertility in three populations of the koala, Phascolarctos cinereus Goldfuss, in Victoria. Wildlife Research, 8, 275283.
  • Martinez, M., Mahmood, I. & Hunter, R.P. (2006) Interspecies allometric scaling: prediction of clearance in large animal species: Part II: mathematical considerations. Journal of Veterinary Pharmacology and Therapeutics, 29, 425432.
  • Mendes, F.E.S., Oliveira, L.V.N., Faria, E.S., Alvarenga, D.G., Pinto, M.R., Taborda, C.P., Soares, B.M., Cisalpino, P.S. & Santos, D.A. (2010) Correlation of the in vitro antifungal drug susceptibility with the in vivo activity of fluconazole in a murine model of cerebral infection caused by Cryptococcus gattii. European Journal of Clinical Microbiology & Infectious Diseases, 29, 15251532.
  • Nagy, K.A. & Martin, R.W. (1985) Field metabolic rate, water flux, food consumption and time budget of koalas, Phascolarctos cinereus (Marsupialia: Phascolarctidae) in Victoria. Australian Journal of Zoology, 33, 655665.
  • Ngo, S., Kong, S., Kirlich, A., McKinnon, R.A. & Stupans, I. (2000) Cytochrome P450 4A, peroxisomal enzymes and nicotinamide cofactors in koala liver. Comparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology, 127, 327334.
  • Pass, M.A. & Brown, A.S. (1990) Liver function in normal koalas and macropods. Australian Veterinary Journal, 67, 151152.
  • Pfeiffer, T.J. & Ellis, D.H. (1992) Environmental isolation of Cryptococcus neoformans var. gattii from Eucalyptus tereticornis. Medical Mycology, 30, 407408.
  • Pillai, V.C. & Venkataramanan, R. (2012) Pharmacokinetics. In Immunotherapy in Transplantation: Principles and Practice. Eds Kaplan, B., Burckart, G.J. & Lakkis, F.G., pp. 8194. Wiley-Blackwell, Oxford.
  • Rex, J.H., Pfaller, M.A., Rinaldi, M.G., Polak, A. & Galgiani, J.N. (1993) Antifungal susceptibility testing. Clinical Microbiology Reviews, 6, 367381.
  • Rex, J.H., Pfaller, M.A., Walsh, T.J., Chaturvedi, V., Espinel-Ingroff, A., Ghannoum, M.A., Gosey, L.L., Odds, F.C., Rinaldi, M.G., Sheehan, D.J. & Warnock, D.W. (2001) Antifungal susceptibility testing: practical aspects and current challenges. Clinical Microbiology Reviews, 14, 643658.
  • Ripa, S., Ferrante, L. & Prenna, M. (1993) Pharmacokinetics of fluconazole in normal volunteers. Chemotherapy, 39, 612.
  • Stalder, K.J. (2003) Further investigations into diseases of the koala (Phascolarctos cinereus). BSc (Vet) thesis, The University of Sydney.
  • Tolins, J.P. & Raij, L. (1988) Adverse effect of amphotericin B administration on renal hemodynamics in the rat. Neurohumoral mechanisms and influence of calcium channel blockade. Journal of Pharmacology and Experimental Therapeutics, 245, 594599.
  • Torres-Rodríguez, J.M., Alvarado-Ramírez, E., Murciano, F. & Sellart, M. (2008) MICs and minimum fungicidal concentrations of posaconazole, voriconazole and fluconazole for Cryptococcus neoformans and Cryptococcus gattii. Journal of Antimicrobial Chemotherapy, 62, 205210.
  • Toutain, P.-L. & Bousquet-Mélou, A. (2004) Volumes of distribution. Journal of Veterinary Pharmacology and Therapeutics, 27, 441453.
  • Toutain, P.-L., Bousquet-Mélou, A. & Martinez, M. (2007) AUC/MIC: a PK/PD index for antibiotics with a time dimension or simply a dimensionless scoring factor? Journal of Antimicrobial Chemotherapy, 60, 11851188.
  • Trilles, L., Fernández-Torres, B., dos Santos Lazéra, M., Wanke, B. & Guarro, J. (2004) In vitro antifungal susceptibility of Cryptococcus gattii. Journal of Clinical Microbiology, 42, 48154817.
  • Vaden, S.L., Heit, M.C., Hawkins, E.C., Manaugh, C. & Riviere, J.E. (1997) Fluconazole in cats: Pharmacokinetics following intravenous and oral administration and penetration into cerebrospinal fluid, aqueous humour and pulmonary epithelial lining fluid. Journal of Veterinary Pharmacology and Therapeutics, 20, 181186.
  • VSN International (2011) GenStat for Windows 14th Edition. VSN International, Hemel Hempstead, UK.
  • Walsh, T.J., Foulds, G. & Pizzo, P.A. (1989) Pharmacokinetics and tissue penetration of fluconazole in rabbits. Antimicrobial Agents and Chemotherapy, 33, 467469.
  • Wynne, J., Klause, S., Stadler, C.K., Pye, G.W., Meyer, W. & Sykes, J.E. (2012) Preshipment testing success: resolution of a nasal sinus granuloma in a captive koala (Phascolarctos cinereus) caused by Cryptococcus gattii. Journal of Zoo and Wildlife Medicine, 43, 939942.
  • Yáñez, J., Brocks, D., Forrest, L. & Davies, N. (2011) Pharmacokinetic behaviors of orally administered drugs. In Oral Bioavailability: Basic Principles, Advanced Concepts, and Applications. Eds Hu, M. & Li, X., pp. 183220. John Wiley & Sons, Inc., Hoboken, New Jersey.
  • Zhang, S., Mada, S.R., Torch, M., Goyal, R.K. & Venkataramanan, R. (2008) Development and validation of a high-performance liquid chromatographic assay for the determination of fluconazole in human whole blood using solid phase extraction. Therapeutic Drug Monitoring, 30, 314319.